Savara to participate in two upcoming investor healthcare conferences

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the following healthcare conferences: h.c. wainwright 23rd annual global investment conference: a pre-recorded webcast of the presentation will be available beginning at 7:00 am et / 4:00 am pt on september 13, 2021. oppenheimer fall healthcare life sciences & medtech summit: a live webcast of th
SVRA Ratings Summary
SVRA Quant Ranking